Perrigo (PRGO) Net Cash Flow (2013 - 2026)
Perrigo's (PRGO) quarterly Net Cash Flow came in at -$171.3 million in Q1 2026, down 12.7% year-on-year from -$196.2 million in Q1 2025, and down 277.51% on a QoQ basis from $96.5 million in Q4 2025.
Perrigo (PRGO) Net Cash Flow (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Net Cash Flow data on file, last reported at -$171.3 million in Q1 2026.
- On a quarterly basis, Net Cash Flow fell 12.7% year-over-year to -$171.3 million in Q1 2026; TTM through Mar 2026 was -$76.7 million, a 67.5% increase from a year earlier, with the FY2025 full-year figure at -$57.4 million, up 66.1% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$171.3 million, down from $96.5 million in the prior quarter.
- Over the last five years, Net Cash Flow for PRGO reached as high as $908.2 million in Q3 2024 and fell as low as -$1.4 billion in Q3 2022.
- Historically, Net Cash Flow has averaged -$87.5 million across 5 years, with a median of -$4.7 million in 2022.
- On a YoY basis, Net Cash Flow climbed as much as 1698.42% in 2024 and fell as far as 113500.0% in 2024.
- Year by year, Net Cash Flow stood at $117.4 million in 2022, then grew by 20.36% to $141.3 million in 2023, then plunged by 721.8% to -$878.6 million in 2024, then jumped by 110.98% to $96.5 million in 2025, then tumbled by 277.51% to -$171.3 million in 2026.
- Per Business Quant data, the three most recent Net Cash Flow figures were -$171.3 million in Q1 2026, $96.5 million in Q4 2025, and -$20.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 202.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -526.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 711.50 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 461.90 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -112.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -171.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -171.30 Mn |
| Mar 28, 2026 | -171.30 Mn |
| Dec 31, 2025 | 96.50 Mn |
| Dec 31, 2025 | 96.50 Mn |
| Sep 27, 2025 | -20.00 Mn |
| Sep 27, 2025 | -20.00 Mn |
| Jun 28, 2025 | 18.10 Mn |
| Jun 28, 2025 | 18.10 Mn |
| Mar 29, 2025 | -152.00 Mn |
| Mar 29, 2025 | -152.00 Mn |
| Dec 31, 2024 | -878.60 Mn |
| Dec 31, 2024 | -878.60 Mn |
| Sep 28, 2024 | 908.20 Mn |
| Sep 28, 2024 | 908.20 Mn |
| Jun 29, 2024 | -113.60 Mn |
| Jun 29, 2024 | -113.60 Mn |
| Mar 30, 2024 | -85.30 Mn |
| Mar 30, 2024 | -85.30 Mn |
| Dec 31, 2023 | 141.30 Mn |
| Dec 31, 2023 | 141.30 Mn |